SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-016369
Filing Date
2015-03-16
Accepted
2015-03-16 16:37:07
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v403478_10k.htm 10-K 783582
2 EXHIBIT 23.1 v403478_ex23-1.htm EX-23.1 2882
3 EXHIBIT 31.1 v403478_ex31-1.htm EX-31.1 10933
4 EXHIBIT 31.2 v403478_ex31-2.htm EX-31.2 10420
5 EXHIBIT 32.1 v403478_ex32-1.htm EX-32.1 3852
6 EXHIBIT 32.2 v403478_ex32-2.htm EX-32.2 3534
13 GRAPHIC tpg10.jpg GRAPHIC 38257
  Complete submission text file 0001144204-15-016369.txt   6710752

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tgtx-20141231.xml EX-101.INS 921725
8 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20141231.xsd EX-101.SCH 63060
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20141231_cal.xml EX-101.CAL 44023
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20141231_def.xml EX-101.DEF 326113
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20141231_lab.xml EX-101.LAB 419536
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20141231_pre.xml EX-101.PRE 373423
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 15703411
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences